DK2479174T3 - 6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser deraf - Google Patents
6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser derafInfo
- Publication number
- DK2479174T3 DK2479174T3 DK10814867.7T DK10814867T DK2479174T3 DK 2479174 T3 DK2479174 T3 DK 2479174T3 DK 10814867 T DK10814867 T DK 10814867T DK 2479174 T3 DK2479174 T3 DK 2479174T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyanquinoline
- aminoquinazoline
- procedures
- derivatives
- pharmaceutical applications
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
- C07F9/65128—Six-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101958233A CN102020639A (zh) | 2009-09-14 | 2009-09-14 | 6-氨基喹唑啉或3-氰基喹啉类衍生物、其制备方法及其在医药上的应用 |
| PCT/CN2010/001293 WO2011029265A1 (zh) | 2009-09-14 | 2010-08-26 | 6-氨基喹唑啉或3-氰基喹啉类衍生物、其制备方法及其在医药上的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2479174T3 true DK2479174T3 (da) | 2017-11-27 |
Family
ID=43731939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10814867.7T DK2479174T3 (da) | 2009-09-14 | 2010-08-26 | 6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser deraf |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US8901140B2 (da) |
| EP (1) | EP2479174B1 (da) |
| JP (1) | JP5684811B2 (da) |
| KR (1) | KR101738191B1 (da) |
| CN (2) | CN102020639A (da) |
| AU (1) | AU2010292790B2 (da) |
| BR (1) | BR112012005760A2 (da) |
| CA (1) | CA2774099C (da) |
| DK (1) | DK2479174T3 (da) |
| ES (1) | ES2647829T3 (da) |
| HK (1) | HK1163081A1 (da) |
| HR (1) | HRP20171748T1 (da) |
| HU (1) | HUE035873T2 (da) |
| LT (1) | LT2479174T (da) |
| MX (1) | MX2012002875A (da) |
| NO (1) | NO2479174T3 (da) |
| PL (1) | PL2479174T3 (da) |
| PT (1) | PT2479174T (da) |
| RU (1) | RU2536102C2 (da) |
| SI (1) | SI2479174T1 (da) |
| WO (1) | WO2011029265A1 (da) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102020639A (zh) | 2009-09-14 | 2011-04-20 | 上海恒瑞医药有限公司 | 6-氨基喹唑啉或3-氰基喹啉类衍生物、其制备方法及其在医药上的应用 |
| CN102675287A (zh) * | 2011-03-11 | 2012-09-19 | 江苏恒瑞医药股份有限公司 | (e)-n-[4-[[3-氯-4-(2-吡啶基甲氧基)苯基]氨基]-3-氰基-7-乙氧基-6-喹啉基]-3-[(2r)-1-甲基吡咯烷-2-基]丙-2-烯酰胺的可药用的盐、其制备方法及其在医药上的应用 |
| CN103717590B (zh) * | 2011-05-17 | 2016-05-11 | 江苏康缘药业股份有限公司 | 喹唑啉-7-醚化合物及使用方法 |
| US9371292B2 (en) | 2011-07-27 | 2016-06-21 | Shanghai Pharmaceuticals Holdings Co., Ltd. | Quinazoline derivative, preparation method therefor, intermediate, composition and application thereof |
| CN103987700B (zh) * | 2012-03-09 | 2016-08-31 | 江苏豪森药业集团有限公司 | 4-喹唑啉胺类衍生物及其用途 |
| CN103539783A (zh) * | 2012-07-12 | 2014-01-29 | 江苏恒瑞医药股份有限公司 | 一种酪氨酸激酶抑制剂的二马来酸盐的i型结晶及制备方法 |
| CN103588755B (zh) * | 2012-08-17 | 2016-06-22 | 正大天晴药业集团股份有限公司 | Neratinib的制备方法 |
| CN103965120B (zh) * | 2013-01-25 | 2016-08-17 | 上海医药集团股份有限公司 | 喹啉及喹唑啉衍生物、制备方法、中间体、组合物及应用 |
| WO2014177038A1 (en) | 2013-04-28 | 2014-11-06 | Sunshine Lake Pharma Co., Ltd. | Aminoquinazoline derivatives and their salts and methods of use thereof |
| WO2015085654A1 (zh) * | 2013-12-12 | 2015-06-18 | 天津合美医药科技有限公司 | 喹唑啉衍生物 |
| CN106068262B (zh) * | 2014-04-11 | 2019-10-29 | 海思科医药集团股份有限公司 | 喹唑啉衍生物及其制备方法和在医药上的应用 |
| MX2018008549A (es) | 2016-01-27 | 2018-09-19 | Jiangsu Hengrui Medicine Co | Composicion farmaceutica que comprende derivado de quinolina o sal del mismo. |
| AU2017211737B2 (en) * | 2016-01-27 | 2022-04-28 | Jiangsu Hengrui Medicine Co., Ltd. | Method for preparing pharmaceutical composition comprising quinoline derivative or salt thereof |
| CN107708698A (zh) * | 2016-01-28 | 2018-02-16 | 江苏恒瑞医药股份有限公司 | 一种egfr/her2受体酪氨酸激酶抑制剂在制备治疗her2突变癌症药物中的用途 |
| CN105777604A (zh) * | 2016-04-14 | 2016-07-20 | 上海凯宝药业股份有限公司 | 一种n-甲基-反式-4-羟基-l-脯氨酸晶体化合物及其制备方法 |
| DK3447051T3 (da) * | 2016-04-28 | 2022-01-17 | Jiangsu Hengrui Medicine Co | Fremgangsmåde til fremstilling af tyrosinkinaseinhibitor og derivat deraf |
| CN106008471B (zh) * | 2016-05-25 | 2019-09-03 | 江苏医诺万细胞诊疗有限公司 | 一种喹唑啉类化合物的合成方法 |
| CN108289885B (zh) * | 2016-09-23 | 2020-10-20 | 江苏恒瑞医药股份有限公司 | 酪氨酸激酶抑制剂在制备治疗癌症药物中的用途 |
| EP3517529B1 (en) * | 2016-09-23 | 2022-03-23 | Shanghai Pharmaceuticals Holding Co., Ltd. | Salt of quinazoline derivative, preparation method therefor and application thereof |
| CN106565692A (zh) * | 2016-11-03 | 2017-04-19 | 常茂生物化学工程股份有限公司 | 一种阿法替尼合成工艺的改进方法 |
| CN113769097A (zh) * | 2017-01-22 | 2021-12-10 | 江苏恒瑞医药股份有限公司 | Egfr/her2抑制剂联合嘧啶类抗代谢药物的用途 |
| WO2019029477A1 (zh) * | 2017-08-07 | 2019-02-14 | 江苏恒瑞医药股份有限公司 | 一种酪氨酸激酶抑制剂的二马来酸盐的晶型及其制备方法 |
| WO2019042409A1 (zh) | 2017-09-01 | 2019-03-07 | 上海医药集团股份有限公司 | 一种含氮杂环化合物、制备方法、中间体、组合物和应用 |
| MX2020004034A (es) * | 2017-10-18 | 2020-08-13 | Jiangsu Hengrui Medicine Co | Metodo de preparacion para un inhibidor de tirosina cinasa e intermediario del mismo. |
| TWI700086B (zh) | 2017-10-24 | 2020-08-01 | 大陸商江蘇恒瑞醫藥股份有限公司 | 一種含有喹啉衍生物的藥物組合物 |
| CN110913894B (zh) * | 2017-10-26 | 2023-03-10 | 江苏恒瑞医药股份有限公司 | 抗csf-1r抗体、其抗原结合片段及其医药用途 |
| CN108314639B (zh) * | 2018-05-09 | 2019-04-30 | 山东铂源药业有限公司 | 化合物（e）-3-（1-甲基吡咯烷-2-基）-丙烯酸盐酸盐及合成方法 |
| CN110840892A (zh) * | 2018-08-21 | 2020-02-28 | 江苏恒瑞医药股份有限公司 | 酪氨酸激酶抑制剂与cdk4/6抑制剂联合在制备预防或***疾病的药物中的用途 |
| CN110960529A (zh) * | 2018-09-30 | 2020-04-07 | 江苏恒瑞医药股份有限公司 | 一种降低了毒性杂质含量的酪氨酸激酶抑制剂的原料药 |
| US20210355109A1 (en) | 2018-10-22 | 2021-11-18 | Jiangsu Hengrui Medicine Co., Ltd. | Crystal form of maleate of tyrosine kinase inhibitor and preparation method therefor |
| CN113195000A (zh) | 2018-12-21 | 2021-07-30 | 第一三共株式会社 | 抗体-药物缀合物和激酶抑制剂的组合 |
| CN112279838B (zh) * | 2020-10-29 | 2021-07-13 | 苏州富士莱医药股份有限公司 | 一种吡咯替尼的制备方法 |
| CN112625025B (zh) * | 2020-12-31 | 2022-03-29 | 河南省医药科学研究院 | 吡啶基取代的喹啉类衍生物及其制备方法和用途 |
| CN112759583B (zh) * | 2020-12-31 | 2022-10-11 | 河南省医药科学研究院 | 包含呋喃基的喹啉类衍生物及其制备方法和用途 |
| CN112694439B (zh) * | 2020-12-31 | 2022-08-30 | 河南省医药科学研究院 | 苯基丙烯酰胺基喹啉类衍生物及其制备方法和用途 |
| JP2024510312A (ja) | 2021-03-19 | 2024-03-06 | 北京賽特明強医薬科技有限公司 | キナゾリン系化合物、キナゾリン系化合物の組成物及び応用 |
| TW202330040A (zh) * | 2021-10-14 | 2023-08-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 抗ｈｅｒ２抗體藥物偶聯物和酪胺酸激酶抑制劑聯合在製備治療腫瘤的藥物中的用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA73073C2 (uk) * | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
| AU763669B2 (en) | 1998-09-29 | 2003-07-31 | Wyeth Holdings Corporation | Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| ES2280375T3 (es) * | 2000-04-08 | 2007-09-16 | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG | Heterociclos biciclicos, medicamentos que contienen estos compuestos, su uso y procedimiento para su preparacion. |
| US7019012B2 (en) | 2000-12-20 | 2006-03-28 | Boehringer Ingelheim International Pharma Gmbh & Co. Kg | Quinazoline derivatives and pharmaceutical compositions containing them |
| DE10217689A1 (de) | 2002-04-19 | 2003-11-13 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung |
| US20040044014A1 (en) * | 2002-04-19 | 2004-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| DE10307165A1 (de) * | 2003-02-20 | 2004-09-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung |
| US7399865B2 (en) * | 2003-09-15 | 2008-07-15 | Wyeth | Protein tyrosine kinase enzyme inhibitors |
| KR100832593B1 (ko) | 2005-11-08 | 2008-05-27 | 한미약품 주식회사 | 신호전달 저해제로서의 퀴나졸린 유도체 및 이의 제조방법 |
| CN101824029A (zh) * | 2009-03-05 | 2010-09-08 | 厦门艾德生物医药科技有限公司 | 酪氨酸激酶不可逆抑制剂、其药物组合物及其用途 |
| CN102020639A (zh) | 2009-09-14 | 2011-04-20 | 上海恒瑞医药有限公司 | 6-氨基喹唑啉或3-氰基喹啉类衍生物、其制备方法及其在医药上的应用 |
-
2009
- 2009-09-14 CN CN2009101958233A patent/CN102020639A/zh active Pending
-
2010
- 2010-08-26 PT PT108148677T patent/PT2479174T/pt unknown
- 2010-08-26 LT LTEP10814867.7T patent/LT2479174T/lt unknown
- 2010-08-26 US US13/395,892 patent/US8901140B2/en active Active
- 2010-08-26 SI SI201031574T patent/SI2479174T1/sl unknown
- 2010-08-26 DK DK10814867.7T patent/DK2479174T3/da active
- 2010-08-26 JP JP2012528211A patent/JP5684811B2/ja active Active
- 2010-08-26 HU HUE10814867A patent/HUE035873T2/en unknown
- 2010-08-26 CA CA2774099A patent/CA2774099C/en active Active
- 2010-08-26 BR BR112012005760A patent/BR112012005760A2/pt not_active Application Discontinuation
- 2010-08-26 PL PL10814867T patent/PL2479174T3/pl unknown
- 2010-08-26 CN CN201080030048.7A patent/CN102471312B/zh active Active
- 2010-08-26 AU AU2010292790A patent/AU2010292790B2/en active Active
- 2010-08-26 NO NO10814867A patent/NO2479174T3/no unknown
- 2010-08-26 KR KR1020127009554A patent/KR101738191B1/ko active IP Right Grant
- 2010-08-26 ES ES10814867.7T patent/ES2647829T3/es active Active
- 2010-08-26 EP EP10814867.7A patent/EP2479174B1/en active Active
- 2010-08-26 MX MX2012002875A patent/MX2012002875A/es active IP Right Grant
- 2010-08-26 WO PCT/CN2010/001293 patent/WO2011029265A1/zh active Application Filing
- 2010-08-26 RU RU2012110882/04A patent/RU2536102C2/ru active
-
2012
- 2012-04-16 HK HK12103680A patent/HK1163081A1/xx unknown
-
2014
- 2014-12-01 US US14/556,792 patent/US9358227B2/en active Active
-
2017
- 2017-11-14 HR HRP20171748TT patent/HRP20171748T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LT2479174T (lt) | 2017-11-27 |
| SI2479174T1 (sl) | 2017-12-29 |
| HUE035873T2 (en) | 2018-05-28 |
| PL2479174T3 (pl) | 2018-02-28 |
| US9358227B2 (en) | 2016-06-07 |
| AU2010292790A1 (en) | 2012-05-10 |
| CN102471312A (zh) | 2012-05-23 |
| CN102020639A (zh) | 2011-04-20 |
| ES2647829T3 (es) | 2017-12-26 |
| BR112012005760A2 (pt) | 2016-02-16 |
| NO2479174T3 (da) | 2018-03-17 |
| RU2012110882A (ru) | 2013-11-10 |
| CA2774099C (en) | 2017-07-04 |
| US8901140B2 (en) | 2014-12-02 |
| EP2479174B1 (en) | 2017-10-18 |
| HRP20171748T1 (hr) | 2017-12-29 |
| KR101738191B1 (ko) | 2017-05-19 |
| CN102471312B (zh) | 2014-06-18 |
| RU2536102C2 (ru) | 2014-12-20 |
| PT2479174T (pt) | 2017-11-20 |
| JP5684811B2 (ja) | 2015-03-18 |
| KR20120081142A (ko) | 2012-07-18 |
| CA2774099A1 (en) | 2011-03-17 |
| AU2010292790B2 (en) | 2015-03-26 |
| HK1163081A1 (en) | 2012-09-07 |
| EP2479174A1 (en) | 2012-07-25 |
| JP2013504521A (ja) | 2013-02-07 |
| US20150126550A1 (en) | 2015-05-07 |
| EP2479174A4 (en) | 2013-04-17 |
| MX2012002875A (es) | 2012-04-20 |
| WO2011029265A1 (zh) | 2011-03-17 |
| US20120165352A1 (en) | 2012-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2479174T3 (da) | 6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser deraf | |
| BRPI1010881A2 (pt) | derivados de triazina e suas aplicações terapêuticas. | |
| DK3292874T3 (da) | Anti-mesothelin-immunkonjugater og anvendelser deraf | |
| BRPI1010882A2 (pt) | derivados de triazina e suas aplicações terapêuticas. | |
| DK2729151T3 (da) | Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf | |
| BR112012011902A2 (pt) | cápsula farmacêutica | |
| BRPI1010768A2 (pt) | composto, e, composição farmacêutica. | |
| BRPI0921919A2 (pt) | dispositivos médicos, aparelhos, sistemas e métodos | |
| DK2490940T3 (da) | Uav-system og fremgangsmåde | |
| BRPI1016117A2 (pt) | derivados de isoxazol-isoxazol e isoxasol-isotiazol. | |
| BRPI0920521A2 (pt) | combinação farmacêutica | |
| BRPI1009372A2 (pt) | compostos, composição farmacêutica e respectivos usos | |
| DK3278665T3 (da) | Stabil farmaceutisk sammensætning og fremgangsmåder til anvendelse deraf | |
| BRPI1011527A2 (pt) | derivados de triazina substituídos com ureidofenil e suas aplicações terapêuticas. | |
| BRPI1013642A2 (pt) | derivado de triazina e composição farmacêutica compreendendo o mesmo | |
| DK2273975T3 (da) | Farmaceutiske opløsninger, fremgangsmåde til fremstilling og terapeutiske anvendelser | |
| DK2245032T3 (da) | Folater, sammensætninger og anvendelser deraf | |
| DK2170827T3 (da) | Indolin-2-oner og aza-indolin-2-oner | |
| BR112012002877A2 (pt) | dilatador e conjunto. | |
| DK2805746T3 (da) | Alkylamido-forbindelser og anvendelser deraf | |
| DK2475649T3 (da) | Indenonderivat og farmaceutisk sammensætning omfattende samme | |
| DK2445883T3 (da) | Heterocykliske sulfonamider, anvendelser og farmaceutiske sammensætniger deraf | |
| DK2154966T3 (da) | Benzimidazoler og farmaceutiske sammensætninger deraf | |
| BR112012010242A2 (pt) | derivados de heteroarilpiperidina e heteroarilpiperazina | |
| DK2437830T4 (da) | Anordning til lægemiddelleveringsindretning og lægemiddelleveringsindretning |